Cancer Research SABCS Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levine, D. A.
Right arrow Articles by Boyd, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levine, D. A.
Right arrow Articles by Boyd, J.
[Cancer Research 61, 908-911, February 1, 2001]
© 2001 American Association for Cancer Research

Advances in Brief

The Androgen Receptor and Genetic Susceptibility to Ovarian Cancer: Results from a Case Series1

Douglas A. Levine and Jeff Boyd2

Gynecology and Breast Research Laboratory, Departments of Surgery and Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021

Our objectives were to test whether polymorphic variation in the (CAG)n repeat of the androgen receptor (AR) gene affects penetrance of germ-line BRCA mutations for ovarian cancer or age of diagnosis for ovarian cancer. Using a case-series study design, 179 consecutive Ashkenazi Jewish ovarian cancer patients were genotyped for AR repeat length and BRCA mutation status. There was no association between AR repeat length and presence of a BRCA mutation. However, ovarian cancer patients from both groups (with or without BRCA mutation) who carried a short AR allele were diagnosed an average of 7.2 (95% confidence interval, 2.3–12.1) years earlier than patients who did not carry a short allele (P = 0.004). These data suggest that AR allele length affects age of diagnosis of ovarian cancer, irrespective of BRCA mutation status.




This article has been cited by other articles:


Home page
 In VivoHome page
A. ARPACI, U. GORMUS, B. DALAN, S. BERKMAN, and T. ISBIR
Investigation of PON1 192 and PON1 55 Polymorphisms in Ovarian Cancer Patients in Turkish Population
In Vivo, May 1, 2009; 23(3): 421 - 424.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. A. Gayther, H. Song, S. J. Ramus, S. K. Kjaer, A. S. Whittemore, L. Quaye, J. Tyrer, D. Shadforth, E. Hogdall, C. Hogdall, et al.
Tagging Single Nucleotide Polymorphisms in Cell Cycle Control Genes and Susceptibility to Invasive Epithelial Ovarian Cancer
Cancer Res., April 1, 2007; 67(7): 3027 - 3035.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
P. C.K. Leung and J.-H. Choi
Endocrine signaling in ovarian surface epithelium and cancer
Hum. Reprod. Update, March 1, 2007; 13(2): 143 - 162.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Simchoni, E. Friedman, B. Kaufman, R. Gershoni-Baruch, A. Orr-Urtreger, I. Kedar-Barnes, R. Shiri-Sverdlov, E. Dagan, S. Tsabari, M. Shohat, et al.
Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population.
PNAS, March 7, 2006; 103(10): 3770 - 3774.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
H. M. Sowter and A. Ashworth
BRCA1 and BRCA2 as ovarian cancer susceptibility genes
Carcinogenesis, October 1, 2005; 26(10): 1651 - 1656.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. L. Terry, I. De Vivo, L. Titus-Ernstoff, M.-C. Shih, and D. W. Cramer
Androgen Receptor Cytosine, Adenine, Guanine Repeats, and Haplotypes in Relation to Ovarian Cancer Risk
Cancer Res., July 1, 2005; 65(13): 5974 - 5981.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
D. Milatiner, D. Halle, M. Huerta, E. J. Margalioth, Y. Cohen, A. Ben-Chetrit, M. Gal, T. Mimoni, and T. Eldar-Geva
Associations between androgen receptor CAG repeat length and sperm morphology
Hum. Reprod., June 1, 2004; 19(6): 1426 - 1430.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
F. Modugno
Ovarian Cancer and Polymorphisms in the Androgen and Progesterone Receptor Genes: A HuGE Review
Am. J. Epidemiol., February 15, 2004; 159(4): 319 - 335.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. Sehouli, A. Mustea, D. Koensgen, and W. Lichtenegger
Interleukin-1 Receptor Antagonist Gene Polymorphism in Epithelial Ovarian Cancer
Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1205 - 1208.
[Abstract] [Full Text]

Home page
 Ann OncolHome page
J. Sehouli, A. Mustea, D. Koensgen, F. C.-K. Chen, and W. Lichtenegger
Interleukin-1 receptor antagonist gene polymorphism is associated with increased risk of epithelial ovarian cancer
Ann. Onc., October 1, 2003; 14(10): 1501 - 1504.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. M. Wenham, J. M. Schildkraut, K. McLean, B. Calingaert, R. C. Bentley, J. Marks, and A. Berchuck
Polymorphisms in BRCA1 and BRCA2 and Risk of Epithelial Ovarian Cancer
Clin. Cancer Res., October 1, 2003; 9(12): 4396 - 4403.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. J. Li, R. L. Baldwin, and B. Y. Karlan
Short Androgen Receptor Allele Length Is a Poor Prognostic Factor in Epithelial Ovarian Carcinoma
Clin. Cancer Res., September 1, 2003; 9(10): 3667 - 3673.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. M. Yousef, A. Scorilas, D. Katsaros, S. Fracchioli, L. Iskander, C. Borgono, I. A. Rigault de la Longrais, M. Puopolo, M. Massobrio, and E. P. Diamandis
Prognostic Value of the Human Kallikrein Gene 15 Expression in Ovarian Cancer
J. Clin. Oncol., August 15, 2003; 21(16): 3119 - 3126.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Evangelou, M. Letarte, I. Jurisica, M. Sultan, K. J. Murphy, B. Rosen, and T. J. Brown
Loss of Coordinated Androgen Regulation in Nonmalignant Ovarian Epithelial Cells with BRCA1/2 Mutations and Ovarian Cancer Cells
Cancer Res., May 15, 2003; 63(10): 2416 - 2424.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
L. A. Hefler, E. Ludwig, A. Lebrecht, R. Zeillinger, D. Tong-Cacsire, H. Koelbl, S. Leodolter, and C. B. Tempfer
Polymorphisms of the Interleukin-1 Gene Cluster and Ovarian Cancer
Reproductive Sciences, November 1, 2002; 9(6): 386 - 390.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
S.-H. Yeh, C.-F. Chang, W.-Y. Shau, Y.-W. Chen, H.-C. Hsu, P.-H. Lee, D.-S. Chen, and P.-J. Chen
Dominance of Functional Androgen Receptor Allele with Longer CAG Repeat in Hepatitis B Virus-related Female Hepatocarcinogenesis
Cancer Res., August 1, 2002; 62(15): 4346 - 4351.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.